BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33212370)

  • 1. Design, implementation, and monitoring of HIV service packages for people who inject drugs: An assessment of programs supported by the Global Fund in 46 countries.
    Burrows D; Falkenberry H; McCallum L; Parsons D; Ngoksin E; Zhao J; Kunii O
    Int J Drug Policy; 2021 Feb; 88():103036. PubMed ID: 33212370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a global index measuring national policy commitments to HIV prevention and treatment among people who inject drugs.
    Sevigny EL; Meylakhs P; Feizollahi MJ; Amini MR
    Int J Drug Policy; 2020 Oct; 84():102877. PubMed ID: 32717705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
    Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
    Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L
    Lancet Glob Health; 2023 May; 11(5):e673-e683. PubMed ID: 36996860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
    Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J
    Am J Public Health; 2020 Jan; 110(1):45-50. PubMed ID: 31725310
    [No Abstract]   [Full Text] [Related]  

  • 9. Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention.
    Smith MK; Solomon SS; Cummings DAT; Srikrishnan AK; Kumar MS; Vasudevan CK; McFall AM; Lucas GM; Celentano DD; Mehta SH
    Int J Drug Policy; 2018 Jul; 57():111-118. PubMed ID: 29730586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.
    Allen ST; White RH; O'Rourke A; Schneider KE; Weir BW; Lucas GM; Kilkenny ME; Sherman SG
    AIDS Behav; 2021 Oct; 25(10):3377-3385. PubMed ID: 33886011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
    Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
    J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.
    Colledge S; Leung J; Larney S; Peacock A; Grebely J; Hickman M; Cunningham E; Trickey A; Stone J; Vickerman P; Degenhardt L
    Int J Drug Policy; 2020 Feb; 76():102619. PubMed ID: 31864107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
    Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
    Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
    Latypov A; Otiashvili D; Zule W
    Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I held on to the police's leg for mercy": Experiences of adversity, risk and harm among people who inject drugs during an anti-drug drive in Dhaka, Bangladesh.
    Khan SI; Irfan SD; Khan MNM
    Int J Drug Policy; 2021 Jun; 92():103299. PubMed ID: 34030931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
    Yang Y; Latkin C; Luan R; Yang C
    Int J Drug Policy; 2016 Jan; 27():113-20. PubMed ID: 26123897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.